Could influenza vaccination prevent myocardial infarction, stroke and sudden cardiac death?

American Journal of Cardiovascular Drugs

Volumn 3, Issue 4, 2003, Pages 241-244

  Meyers, David G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DISEASE PREDISPOSITION; DRUG TOLERABILITY; GUILLAIN BARRE SYNDROME; HEART ARREST; HEART DEATH; HEMOSTASIS; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEASONAL VARIATION; STROKE; SUDDEN DEATH; SYSTEMIC DISEASE; THROMBOSIS; UNSTABLE ANGINA PECTORIS; UPPER RESPIRATORY TRACT INFECTION; WINTER;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; HUMANS; INFLUENZA VACCINES; MYOCARDIAL INFARCTION; SEASONS;

EID: 0041328669     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200303040-00002     Document Type: Review

References (47)

1. American Heart Association. 2002 Heart and stroke statistical update. Dallas (TX): American Heart Association, 2001
2. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674-7
3. Naghavi M, Barlas Z, Saidaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039-45
4. Nichol JL, Nordin J, Heckbert SR, et al. Influenza vaccination and reduction of hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-32
5. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513-8
6. Gurfinkle EP, Leon de la Fuente R, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) study. Circulation 2002; 105: 2143-7
7. Libby P. Changing concepts of atherosclerosis. J Intern Med 2000; 247: 349-58
8. Shah PK. Plaque disruption and thrombosis. Cardiol Clin 1999; 17: 271-81
9. Zaman AG, Helft G, Worthley SG, et al. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000; 149: 251-66
10. Spencer FA, Goldberg RJ, Becker RC, et al. Seasonal distribution of acute myocardial infarction in the second national registry of myocardial infarction. J Am Coll Cardiol 1998; 31: 1226-33
11. Sheth T, Nair C, Muller J, et al. Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Cardiol 1999; 33: 1916-9
12. Jakovljevic D, Salomaa V, Sivenius J, et al. Seasonal variation in the occurrence of stroke in the Finnish adult population: The FINMONICA Stroke Register. Stroke 1996; 27: 1774-9
13. Ku CS, Yang CY, Chiang HT, et al. Absence of seasonal variation in myocardial infarction onset in a region without temperature extremes. Cardiology 1998; 89: 277-82
14. Monto AS, Sullivan KM. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-60
15. Monto AS, Koopman JS, Bryan ER. The Tecumseh study of illness: XIV. occurrence of respiratory viruses, 1976-1981. Am J Epidemiol 1986; 124: 359-67
16. Kawahara J, Sano H, Fukuzaki H, et al. Acute effects of exposure to cold on blood pressure, platelet function, and sympathetic nervous activity in humans. Am J Hypertens 1989; 2: 724-6
17. Gordon DJ, Hydes J, Trost DC, et al. Cyclic seasonal variation in plasma lipid and lipoprotein levels: the Lipid Research Clinics Coronary Primary Prevention Trial Placebo Control Group. J Clin Epidemiol 1988; 41: 679-89
18. Bull GM, Brozovic M, Chakrabarti R, et al. Relationship of air temperature to various chemical, haematologic, and haemostatic variables. J Clin Pathol 1979; 32: 16-20
19. Bussfeld D, Bacher M, Moritz A, et al. Expression of transcription factor genes after influenza A virus infection. Immunobiology 1997; 198: 291-8
20. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000; 84: 149-61
21. Woodhouse PR, Khaw KT, Plummer M, et al. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and deaths from cardiovascular disease. Lancet 1994; 343: 435-9
22. Gronholdt MLM, Dalager-Pederen S, Falk E. Coronary atherosclerosis: determinants of plaque rupture. Eur Heart J 1998; 19 Suppl. C: C24-9
23. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71
24. Visser MR, Tracy PB, Vercellotti GM, et al. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci U S A 1988; 85: 8227-30
25. Etingin OR, Silverstein RL, Hajjar DP. Von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci U S A 1992; 90: 5153-6
26. Key NS, Vercellotti GM, Winklemann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A 1990; 87: 7095-9
27. van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM, et al. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992; 68: 364-70
28. Van Lenten BJ, Wagner AC, Navab M, et al. Acute influenza A infection promotes increased macrophage infiltration into the artery wall that is prevented by apolipoprotein A-1. Circulation 2001; 104 Suppl. II: II-97
29. Osler W. Diseases of the arteries. In: Osler W, editor. Modern medicine: its practice and theory. Philadelphia (PA): Lea & Febiger, 1908: 429-47
30. Gordon T, Thom T. The recent decrease in CHD mortality. Prev Med 1975; 4: 115-25
31. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101: 512-3
32. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-2
33. Jick H, Vasilakis C, Derby LE. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated essential hypertension. Epidemiology 1997; 8: 446-8
34. Zheng ZJ, Mittleman MA, Tolfer GH, et al. Infections prior to acute myocardial infarction onset [abstract]. J Am Coll Cardiol 1998; 31 Suppl. A: 132A
35. Pettinen J, Valonen P. The risk of myocardial infarction among Finnish farmers seeking medical care for an infection. Am J Public Health 1996; 86: 1440-2
36. Gillum RF, Jacobs Jr DR, Luepker RV, et al. Cardiovascular mortality trends in Minnesota, 1960-1978: the Minnesota Heart Survey. J Chronic Dis 1984; 37: 301-9
37. Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in recurrent coronary events. Am J Epidemiol 2002; 156: 634-40
38. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-6
39. Minick CR, Fabricant CG, Fabricant J, et al. Atherosclerosis induced by infection with herpesvirus. Am J Pathol 1979; 96: 673-706
40. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002; 91: 2-4
41. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-27
42. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-5
43. Roacelli JD, Bass JW, Pang L. Guillain-Barre syndrome and influenza vaccination in the US Army, 1980-1988. Am J Epidemiol 1991; 133: 952-5
44. Kasky T, Terracciano GL, Magder L, et al. The Guillian-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-802
45. Nichol KL, Margolis KL, Lind A, et al. Side effects associated with influenza vaccination in healthy working adults. Arch Intern Med 1996; 156: 1546-50
46. Govaert TME, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: randomized double blind placebo controlled trial. BMJ 1996; 307: 988-90
47. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged >65 years: United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50: 532-7